Loading…

The Association of Human Leukocyte Antigens Complex with Type 1 Diabetes in the Omani Population

Identification of the high risk alleles, genotypes and haplotypes of the human leukocyte antigens (HLA) in different populations is beneficial for understanding their roles in type 1 diabetes (T1D) pathogenesis and intervention practices. This study aimed to identify T1D-associated HLA gene alleles...

Full description

Saved in:
Bibliographic Details
Published in:Sultan Qaboos University medical journal 2023-02, Vol.23 (1), p.68-75
Main Authors: Al-Balushi, Mohammed, Al-Badi, Samiya, Al-Yaarubi, Saif, Al-Riyami, Hamad, Al-Shidhani, Azza, Al-Hinai, Shaima, Alshirawi, Ali, Hasson, Sidgi, Said, Elias, Al-Jabri, Ali, Al Ansari, Aliya
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Identification of the high risk alleles, genotypes and haplotypes of the human leukocyte antigens (HLA) in different populations is beneficial for understanding their roles in type 1 diabetes (T1D) pathogenesis and intervention practices. This study aimed to identify T1D-associated HLA gene alleles in the Omani population. The present case-control study included 73 diabetic seropositive children (mean age 9.08 ± 3.27 years) attending the paediatric clinic at Sultan Qaboos University Hospital in Muscat, Oman, and 110 healthy controls. , , , and genes were genotyped using a sequence-specific primer polymerase chain reaction (SSP-PCR). Two HLA class I alleles ( , ) and three class II alleles ( , and ) were associated with T1D susceptibility, while one class I ( ) and three class II ( , and ) alleles were associated with T1D protection. and alleles showed the strongest risk association among all alleles. Six residues (E , S , S , Y , V and K ) were significantly associated with T1D susceptibility. Heterozygous genotypes, / and / were significantly associated with T1D susceptibility (
ISSN:2075-0528
2075-051X
2075-0528
DOI:10.18295/squmj.2.2022.016